Treatment response in clinical practice is in agreement with those obtained in randomized clinical trials (RCT)

a prospective observational study of efalizumab (Raptiva®) in DenmarkP02

  • Gniadecki, R.
  • Kragballe, K.

  • Department of Dermatology, Bispbebjerg Hospital, University of Copenhagen, Copenhagen, Denmark and *Department of Dermatology, Aarhus University Hospital, University of Aarhus, Aarhus, Denmark

British Journal of Dermatology 159(6):p 1400, December 2008.
Copyright © 2008 British Association of Dermatologists